Mitoxantrone
Showing 376 - 400 of 438
Multiple Sclerosis Trial in Columbus (mycophenolate mofetil (Cellcept), human interferon beta 1a (Rebif))
Completed
- Multiple Sclerosis
- mycophenolate mofetil (Cellcept)
- human interferon beta 1a (Rebif)
-
Columbus, OhioThe Ohio State University Multiple Sclerosis Center
Nov 14, 2012
Metastatic Prostate Cancer Trial in United States (Mitoxantrone, Prednisone, Sorafenib)
Terminated
- Metastatic Prostate Cancer
- Mitoxantrone
- +2 more
-
La Verne, California
- +9 more
Sep 13, 2011
Tumors, Prostate Cancer Trial in Nashville (Satraplatin)
Terminated
- Tumors
- Prostate Cancer
-
Nashville, TennesseeSarah Cannon Research Institute
May 9, 2012
Leukemia Trial in United States (biological, drug, procedure, radiation)
Completed
- Leukemia
- sargramostim
- +17 more
-
Aurora, Colorado
- +93 more
Nov 21, 2012
Tumors Trial in United States (Liposome Encapsulated Mitoxantrone (LEM))
Completed
- Tumors
- Liposome Encapsulated Mitoxantrone (LEM)
-
Duarte, California
- +3 more
Jun 2, 2011
Leukemia, Promyelocytic, Acute Trial in Dresden (all-trans retinoid acid, idarubicin, mitoxantrone)
Unknown status
- Leukemia, Promyelocytic, Acute
- all-trans retinoid acid
- +4 more
-
Dresden, GermanyDepartment of Medicine I, University Hospital Carl Gustav Carus
Jul 8, 2011
Hormone-Refractory Prostate Cancer Trial in Singapore (Docetaxel, Carboplatin)
Completed
- Hormone-Refractory Prostate Cancer
- Docetaxel, Carboplatin
-
Singapore, SingaporeNational University Hospital
Mar 30, 2012
Prostate Cancer Trial in Caen (etoposide, mitoxantrone HCl, prednisone)
Completed
- Prostate Cancer
- etoposide
- +3 more
-
Caen, FranceCentre Regional Francois Baclesse
May 13, 2011
Relapsing Remitting Multiple Sclerosis Trial (glatiramer acetate 20 mg, glatiramer acetate 20 mg, with mitoxantrone)
Completed
- Relapsing Remitting Multiple Sclerosis
- glatiramer acetate 20 mg
- glatiramer acetate 20 mg, with mitoxantrone
- (no location specified)
Apr 13, 2011
Leukemia Trial in Marseille (amsacrine, busulfan, cytarabine)
Completed
- Leukemia
- amsacrine
- +8 more
-
Marseille, FranceMarseille Institute of Cancer - Institut J. Paoli and I. Calmett
May 12, 2011
Ovarian Cancer Trial in Washington (mitoxantrone HCl, thiotepa, topotecan HCl)
Completed
- Ovarian Cancer
- mitoxantrone hydrochloride
- +3 more
-
Washington, District of ColumbiaVincent T. Lombardi Cancer Research Center, Georgetown Universit
Mar 22, 2011
Leukemia Trial in Buffalo (filgrastim, sargramostim, cytarabine)
Completed
- Leukemia
- filgrastim
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 7, 2011
Tumors, Prostatic Tumors Trial in Worldwide (cabazitaxel (XRP6258) (RPR116258), mitoxantrone, prednisone)
Completed
- Neoplasms
- Prostatic Neoplasms
- cabazitaxel (XRP6258) (RPR116258)
- +2 more
-
Bridgewater, New Jersey
- +25 more
Mar 4, 2011
Leukemia Trial (filgrastim, cytarabine, etoposide)
Completed
- Leukemia
- filgrastim
- +3 more
- (no location specified)
Feb 9, 2011
Prostate Cancer Trial in France (mitoxantrone HCl, vinorelbine tartrate)
Unknown status
- Prostate Cancer
- mitoxantrone hydrochloride
- vinorelbine tartrate
-
Amiens, France
- +9 more
Feb 26, 2011
Leukemia, Nonlymphocytic, Acute Trial in Dresden (randomization between two established Chemotherapies)
Completed
- Leukemia, Nonlymphocytic, Acute
- randomization between two established Chemotherapies
-
Dresden, Sachsen, GermanyUniversitätsklinikum
Aug 19, 2010
Role of Gene Variation in Effectiveness of Gleevec Treatment
Completed
- Cancer
- Breast Cancer
-
Washington, District of Columbia
- +1 more
May 24, 2011
Ovarian Cancer Trial in Seattle (endocrine-modulating drug therapy, melphalan, mitoxantrone HCl)
Completed
- Ovarian Cancer
- endocrine-modulating drug therapy
- +5 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Sep 13, 2010
Leukemia, MDS Trial in Seattle (biological, drug, procedure)
Completed
- Leukemia
- Myelodysplastic Syndromes
- aldesleukin
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Sep 16, 2010
Leukemia, Lymphoma Trial in Cleveland (sargramostim, cytarabine, mitoxantrone HCl)
Completed
- Leukemia
- Lymphoma
- sargramostim
- +2 more
-
Cleveland, OhioIreland Cancer Center at University Hospitals Case Medical Cente
Jun 10, 2010
DLBCL, IPI=2 Trial in Italy (Rituximab, Ciclofosfamide, Doxorubicina)
Unknown status
- Diffuse Large B-Cell Lymphoma
- IPI≥2
- Rituximab
- +11 more
-
Nocera Inferiore, Salerno, Italy
- +74 more
Feb 14, 2011